1. Home
  2. BKU vs PBLS Comparison

BKU vs PBLS Comparison

Compare BKU & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

N/A

Current Price

$43.04

Market Cap

3.3B

Sector

Finance

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.27

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BKU
PBLS
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
BKU
PBLS
Price
$43.04
$28.27
Analyst Decision
Hold
Strong Buy
Analyst Count
11
6
Target Price
★ $46.82
$41.40
AVG Volume (30 Days)
870.5K
★ 1.1M
Earning Date
10-21-2026
11-17-2026
Dividend Yield
★ 3.04%
N/A
EPS Growth
★ 14.61
N/A
EPS
★ 1.79
N/A
Revenue
★ $21,732,000.00
N/A
Revenue This Year
$3.98
N/A
Revenue Next Year
$4.93
$300.17
P/E Ratio
$24.18
★ N/A
Revenue Growth
★ 7.45
N/A
52 Week Low
$38.01
$22.66
52 Week High
$52.11
$42.49

Technical Indicators

Market Signals
Indicator
BKU
PBLS
Relative Strength Index (RSI) 49.68 49.68
Support Level $41.36 $26.42
Resistance Level $43.63 $41.72
Average True Range (ATR) 1.02 2.39
MACD 0.22 0.64
Stochastic Oscillator 66.37 81.81

Price Performance

Historical Comparison
BKU
PBLS

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses. The company also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products including commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: